Adicet Bio, Inc.ACETNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +111.37% | +104.17% | +15.18% | +0.50% | +0.26% |
| Weighted Average Shares Diluted Growth | +111.37% | +104.17% | +15.18% | +0.50% | +0.26% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | -19.52% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +5.45% | +6.23% | -34.74% | -39.38% | -42.89% |
| Book Value per Share Growth | -48.59% | -46.29% | -45.84% | -43.56% | -48.54% |
| Debt Growth | -16.51% | -17.64% | -18.92% | -19.73% | -14.63% |
| R&D Expense Growth | +0.33% | -6.00% | -4.53% | +9.74% | -12.95% |
| SG&A Expenses Growth | +4.03% | +9.74% | +32.84% | -42.89% | -26.10% |